One key inflammatory cytokine mediating almost all stages of liver diseases is transforming growth factor beta (TGFβ) as it contributes to lipid accumulation by deregulating lipid metabolism and enhancing apoptosis of lipid-accumulating hepatocytes, thus leading to progression of NASH to fibrosis [4]. This evidence concerns the gene TGFB1 and liver disorder.